Last updated on July 2019

Prevalence of Severe Asthma in Spanish Hospitals


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Asthma
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria

  • Group A: Subjects with Severe asthma can be enrolled, when they fulfill the following
    criteria
  • Subjects >= 18 years
  • Subjects diagnosed with "severe asthma" defined as asthma that requires high-dose inhaled corticosteroids (ICS) plus Long-Acting Beta2-Agonist (LABA), leukotriene modifier/ theophylline in the last 12 months or continuous/almost continuous treatment with systemic glucocorticosteroids (CS) for >= 50% of the previous year to maintain control of asthma
  • Subjects treated with ICS/LABA, with the maximum dose recommended by Specific Product Characteristics (SPC).
  • Subjects who give voluntary written informed consent after explanation of studys procedures.
  • Group B: Subjects with Non-Severe asthma can be enrolled, when they fulfill the following criteria:
  • Subjects >= 18 years
  • Subjects diagnosed with non-severe asthma per GINA Guidelines Classification
  • Subjects who give voluntary written informed consent after explanation of studys procedures

Exclusion Criteria

  • Subjects who are not able to complete all the follow-ups of the study with all the study procedures

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.